TBI-treated mice exhibit reduced proliferative and adipogenic capacity in SAT (12) and develop systemic insulin resistance on high-fat diets, accompanied by decreased insulin responsiveness of preadipocytes isolated from VAT (13). This evidence concerns the gene INS and Insulin resistance.